Non-Current Liabilities
Operating Lease Liabilities
Edwards Lifesciences Operating Lease Liabilities decreased by 3.0% to $80.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.8%, from $77.90M to $80.10M. Over 5 years (FY 2020 to FY 2025), Operating Lease Liabilities shows an upward trend with a 2.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ4 2025
How to read this metric
An increase reflects long-term expansion of the leased asset base, while a decrease indicates a reduction in long-term lease commitments.
Detailed definition
This represents the portion of operating lease obligations that are due beyond the next twelve months. It reflects the l...
Peer comparison
Standard long-term liability for companies with significant real estate or equipment footprints.
Metric ID:
operating_lease_liabilities_non_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $63.70M | $64.40M | $69.10M | $68.40M | $63.50M | $67.10M | $69.50M | $66.20M | $63.50M | $70.00M | $73.00M | $77.20M | $74.20M | $85.00M | $78.90M | $77.90M | $78.70M | $75.30M | $82.60M | $80.10M |
| QoQ Change | — | +1.1% | +7.3% | -1.0% | -7.2% | +5.7% | +3.6% | -4.7% | -4.1% | +10.2% | +4.3% | +5.8% | -3.9% | +14.6% | -7.2% | -1.3% | +1.0% | -4.3% | +9.7% | -3.0% |
| YoY Change | — | — | — | — | -0.3% | +4.2% | +0.6% | -3.2% | +0.0% | +4.3% | +5.0% | +16.6% | +16.9% | +21.4% | +8.1% | +0.9% | +6.1% | -11.4% | +4.7% | +2.8% |
Range$63.50M – $85.00M
CAGR+4.9%
Avg YoY Growth+4.8%
Median YoY Growth+4.3%
Operating Lease Liabilities at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's operating lease liabilities?
- Edwards Lifesciences (EW) reported operating lease liabilities of $80.10M in Q1 2026.
- How has Edwards Lifesciences's operating lease liabilities changed year-over-year?
- Edwards Lifesciences's operating lease liabilities increased by 2.8% year-over-year, from $77.90M to $80.10M.
- What is the long-term trend for Edwards Lifesciences's operating lease liabilities?
- Over 5 years (2020 to 2025), Edwards Lifesciences's operating lease liabilities has grown at a 2.6% compound annual growth rate (CAGR), from $72.70M to $82.60M.
- What does operating lease liabilities mean?
- The amount of lease payments due after one year.